Virtual Library

Start Your Search

Lawrence Einhorn



Author of

  • +

    D02 - Optimal therapy for stage 4 NSCLC patient with low PD-L1 expression (1-49%) (ID D02)

    • Event: TTLC 2020
    • Type: General Session
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 2/20/2020, 15:20 - 15:35,
    • +

      PD-1 Inhibition (ID D02.03)

      15:20 - 15:35  |  Author(s): Lawrence Einhorn

      • Abstract

      Abstract not provided